Introduction and Mission

The Waisman Clinical BioManufacturing Facility (WCBF) at the University of Wisconsin-Madison is a state-of-the-art cleanroom facility that is equipped with experienced staff and specialized equipment that are necessary for GMP manufacturing of cell therapeutics, gene therapy vectors, and biologics for phase I/II human clinical trials.  

The primary mission of the WCBF is to serve researchers as they enter early development of novel biological therapies and to catalyze the advancement of therapies into human clinical trials.

The WCBF can assist with your contract manufacturing needs for novel therapeutics including:

Plasmid DNA                                    Recombinant Proteins
Viral Vectors                                    Cell Therapeutics
Aseptic Filling

The WCBF is also capable of providing services such as process development, analytical methods development, analysis of biologics, and quality assurance. With its broad and comprehensive capabilities, the WCBF specializes in assisting researchers and companies with the entire process of developing a manufacturing process and producing and testing materials for human clinical trials.